REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
04/04/2026
Back to search
Official data from USPTO
HENSIFY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
04/05/2026
Trademark type
Word
Nice classes
5, 10
Filing date
05/12/2016
Registration date
04/04/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/24/2023
Last transaction
04/05/2026
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
FR
Examiner
KIDWELL WALKER, JACLYN NOEMI
Law office
M30
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
NANOBIOTIX
Representatives
Paul Cosmovici
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical productsnamely agents for the treatment of tumors in the field of radiation therapy; medicines for humans for the treatment of cancer; health productspharmaceutical preparations for cancer treatment; preparations for medical useparticularly for tumor treatment; radiological contrast substances for medical use; chemical reagents for medical use; chemical preparations for medical and pharmaceutical use being drug delivery agents in the form of tablets and capsules for the treatment of cancer; drugs for medical use for the treatment of cancer; chemico-pharmaceutical products being tablets for the treatment of cancer; diagnostic biomarking reagents for medical use
Class 10
Testing apparatus for medical usenamely medical X-ray apparatus; diagnostic apparatus for medical usenamely medical X-ray apparatus; apparatus for medical usenamely therapeutic mattressesbedsseats and cushions; screens for medical use
Publications
History of USPTO decisions and trademark events.
31 publications found
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/30/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/30/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/30/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
10/24/2023
71AG
REGISTERED-SEC.71 ACCEPTED
10/24/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/21/2023
ES71
TEAS SECTION 71 RECEIVED
03/27/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/28/2017
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2017
FIMP
FINAL DISPOSITION PROCESSED
07/08/2017
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/04/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
04/04/2017
GPNX
NOTIFICATION PROCESSED BY IB
01/26/2017
PUBO
PUBLISHED FOR OPPOSITION
01/17/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
01/11/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
01/11/2017
NPUB
NOTICE OF PUBLICATION
12/28/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/09/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/09/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/09/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/09/2016
RFNT
REFUSAL PROCESSED BY IB
09/23/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/08/2016
RFRR
REFUSAL PROCESSED BY MPU
09/08/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
09/03/2016
CNRT
NON-FINAL ACTION WRITTEN
09/02/2016
DOCK
ASSIGNED TO EXAMINER
08/29/2016
MAFR
APPLICATION FILING RECEIPT MAILED
08/16/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/12/2016
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
08/11/2016
Continuous trademark protection
Get notified about every new filing that threatens HENSIFY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.